Literature DB >> 25655810

Norovirus infections and seroprevalence of genotype GII.4-specific antibodies in a Spanish population.

Noelia Carmona-Vicente1, Manuel Fernández-Jiménez, Juan M Ribes, Carlos J Téllez-Castillo, Parisá Khodayar-Pardo, Jesús Rodríguez-Diaz, Javier Buesa.   

Abstract

Genotype II.4 noroviruses (NoVs) are a leading cause of epidemic acute gastroenteritis in children and adults worldwide. The prevalence of different NoV genotypes causing outbreaks and sporadic cases of acute gastroenteritis in the region of Valencia, Spain, during a 4-year period (2008-11) was investigated. NoVs were detected in 42 out of 55 (76.3%) outbreaks and in 26 out of 332 (7.8%) sporadic cases of acute gastroenteritis. Genogroup GII strains were predominant in outbreaks and sporadic cases. Different genotype GII.4 variants were found (Yerseke_2006a, Den Haag_2006b, Apeldoorn_2007, and New Orleans_2009), with the latter variant detected most frequently (35.3%). A recombinant P domain of the NoV GII.4 Apeldoorn_2007 variant was produced in Escherichia coli and used as the coating antigen in an enzyme immunoassay to survey the IgG antibody seroprevalence against NoV GII.4 in a Spanish population. Baculovirus-expressed virus-like particles (VLPs) of NoV GII.4 Den Haag_2006b variant were also produced and used as antigen to compare seroreactivity. Of the 434 serum specimens analyzed, 429 (98.6%) had antibodies against the P domain. The comparison of reactivities of 30 serum samples to the NoV GII.4 P polypeptide and VLP showed reproducible results with a correlation coefficient of r = 0.794. Titers of antibodies to the P domain increased gradually and significantly with age, reaching the highest levels at the age group of 41-50 years. These results confirm the high prevalence of NoV GII.4 infections in Valencia from early childhood.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  EIA; GII.4; IgG antibodies; genotypes; norovirus

Mesh:

Substances:

Year:  2015        PMID: 25655810     DOI: 10.1002/jmv.24112

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  8 in total

1.  Characterization of a Novel Conformational GII.4 Norovirus Epitope: Implications for Norovirus-Host Interactions.

Authors:  Noelia Carmona-Vicente; Susana Vila-Vicent; David Allen; Roberto Gozalbo-Rovira; Miren Iturriza-Gómara; Javier Buesa; Jesús Rodríguez-Díaz
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

2.  Fractal-fractional and stochastic analysis of norovirus transmission epidemic model with vaccination effects.

Authors:  Ting Cui; Peijiang Liu; Anwarud Din
Journal:  Sci Rep       Date:  2021-12-21       Impact factor: 4.379

Review 3.  Norovirus vaccines: Correlates of protection, challenges and limitations.

Authors:  Nada M Melhem
Journal:  Hum Vaccin Immunother       Date:  2016-02-02       Impact factor: 3.452

4.  Characterisation of a household norovirus outbreak occurred in Valencia (Spain).

Authors:  Noelia Carmona-Vicente; Manuel Fernández-Jiménez; Susana Vila-Vicent; Jesús Rodríguez-Díaz; Javier Buesa
Journal:  BMC Infect Dis       Date:  2016-03-12       Impact factor: 3.090

Review 5.  Norovirus transmission dynamics: a modelling review.

Authors:  K A M Gaythorpe; C L Trotter; B Lopman; M Steele; A J K Conlan
Journal:  Epidemiol Infect       Date:  2017-12-22       Impact factor: 4.434

6.  Sera Antibody Repertoire Analyses Reveal Mechanisms of Broad and Pandemic Strain Neutralizing Responses after Human Norovirus Vaccination.

Authors:  Lisa C Lindesmith; Jonathan R McDaniel; Anita Changela; Raffaello Verardi; Scott A Kerr; Veronica Costantini; Paul D Brewer-Jensen; Michael L Mallory; William N Voss; Daniel R Boutz; John J Blazeck; Gregory C Ippolito; Jan Vinje; Peter D Kwong; George Georgiou; Ralph S Baric
Journal:  Immunity       Date:  2019-06-18       Impact factor: 31.745

7.  Norovirus-Specific Memory T Cell Responses in Adult Human Donors.

Authors:  Maria Malm; Kirsi Tamminen; Timo Vesikari; Vesna Blazevic
Journal:  Front Microbiol       Date:  2016-10-03       Impact factor: 5.640

8.  Comparison of norovirus genogroup I, II and IV seroprevalence among children in the Netherlands, 1963, 1983 and 2006.

Authors:  Janko van Beek; Miranda de Graaf; Ming Xia; Xi Jiang; Jan Vinjé; Mathias Beersma; Erwin de Bruin; David van de Vijver; Melle Holwerda; Marlies van Houten; Annemarie M Buisman; Rob van Binnendijk; Albert D M E Osterhaus; Fiona van der Klis; Harry Vennema; Marion P G Koopmans
Journal:  J Gen Virol       Date:  2016-06-30       Impact factor: 3.891

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.